Primary lung cancers are the leading cause of cancer-related deaths in the United States (estimated 154,050 deaths in 2018, 25.3% of all cancer-related deaths).
Divided into two broad...
May be asymptomatic for most of course
Cough (new or change in chronic cough)
Wheezing and stridor
Pneumonitis (fever and productive cough)
Stage I, stage II, and selected stage III tumors are surgically resectable. Neoadjuvant or adjuvant therapy is recommended for many patients with high risk IB, II, and I...
Depends on clinical history; in general, postoperative visits every 3 to 6 months in the first 2 years after surgery with physical exam and CT s...
C34.90 Malignant neoplasm of unsp part of unsp bronchus or lung
C34.10 Malignant neoplasm of upper lobe, unsp bronchus or lung
C34.30 Malignant neoplasm of lower lobe, unsp bronchus or lung
Two types: NSCLC and SCLC
NSCLC (>85% of all lung cancers); normally originate in periphery
Adenocarcinoma (~40% of NSCLC)
SCC (~25% of NSCLC)
Large cell (~10% of NSCLC)
SCLC centrally l...
Sign up for a 10-day FREE Trial now and receive full access to all content.
FIGURE 1.31. Positron emission tomography (PET) in staging of lung cancer. A, B: Chest radiographs in a 64-year-old woman show a left hilar mass. C: Computed tomography (CT) confirms a left hilar mass and shows a left effusion. D: PET scan confirms marked increased uptake in the left hilar mass. E: PET also shows diffuse increased uptake in the left pleural space, compatible with malignant pleural effusion. F: In addition, a left supraclavicular node is found on PET that was not identified ...
FIGURE 1.31. Positron emission tomography (PET) in staging of lung cancer. A, B: Chest radiographs in a 64-year-old woman show a left hilar...